Literature DB >> 23221482

Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia.

Melissa B Glier1, Ying F Ngai, Dian C Sulistyoningrum, Rika E Aleliunas, Teodoro Bottiglieri, Angela M Devlin.   

Abstract

DNA methylation is linked to homocysteine metabolism through the generation of S-adenosylmethionine (AdoMet) and S-Adenosylhomocysteine (AdoHcy). The ratio of AdoMet/AdoHcy is often considered an indicator of tissue methylation capacity. The goal of this study is to determine the relationship of tissue AdoMet and AdoHcy concentrations to allele-specific methylation and expression of genomically imprinted H19/Igf2. Expression of H19/Igf2 is regulated by a differentially methylated domain (DMD), with H19 paternally imprinted and Igf2 maternally imprinted. F1 hybrid C57BL/6J x Castaneous/EiJ (Cast) mice with (+/-), and without (+/+), heterozygous disruption of cystathionine-β-synthase (Cbs) were fed a control diet or a diet (called HH) to induce hyperhomocysteinemia and changes in tissue AdoMet and AdoHcy. F1 Cast x Cbs+/- mice fed the HH diet had significantly higher plasma total homocysteine concentrations, higher liver AdoHcy, and lower AdoMet/AdoHcy ratios and this was accompanied by lower liver maternal H19 DMD allele methylation, lower liver Igf2 mRNA levels, and loss of Igf2 maternal imprinting. In contrast, we found no significant differences in AdoMet and AdoHcy in brain between the diet groups but F1 Cast x Cbs+/- mice fed the HH diet had higher maternal H19 DMD methylation and lower H19 mRNA levels in brain. A significant negative relationship between AdoHcy and maternal H19 DMD allele methylation was found in liver but not in brain. These findings suggest the relationship of AdoMet and AdoHcy to gene-specific DNA methylation is tissue-specific and that changes in DNA methylation can occur without changes in AdoMet and AdoHcy.

Entities:  

Keywords:  DNA methylation; H19; Igf2; allele-specific; gene expression; genomic imprinting; homocysteine; tissue-specific

Mesh:

Substances:

Year:  2012        PMID: 23221482      PMCID: PMC3549880          DOI: 10.4161/epi.23063

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  40 in total

1.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

2.  Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.

Authors:  S Dayal; T Bottiglieri; E Arning; N Maeda; M R Malinow; C D Sigmund; D D Heistad; F M Faraci; S R Lentz
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

3.  Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation.

Authors:  P Yi; S Melnyk; M Pogribna; I P Pogribny; R J Hine; S J James
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

4.  Parental imprinting of the mouse H19 gene.

Authors:  M S Bartolomei; S Zemel; S M Tilghman
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

5.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific.

Authors:  Silvina F Choumenkovitch; Jacob Selhub; Pamela J Bagley; Nobuyo Maeda; Marie R Nadeau; Donald E Smith; Sang-Woon Choi
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

7.  Homocysteine levels and the risk of osteoporotic fracture.

Authors:  Joyce B J van Meurs; Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Marjolein van der Klift; Robert de Jonge; Jan Lindemans; Lisette C P G M de Groot; Albert Hofman; Jacqueline C M Witteman; Johannes P T M van Leeuwen; Monique M B Breteler; Paul Lips; Huibert A P Pols; André G Uitterlinden
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

8.  Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.

Authors:  Rita Castro; Isabel Rivera; Eduard A Struys; Erwin E W Jansen; Paula Ravasco; Maria Ermelinda Camilo; Henk J Blom; Cornelis Jakobs; Isabel Tavares de Almeida
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

Review 9.  Genomic imprinting mechanisms in mammals.

Authors:  Folami Y Ideraabdullah; Sebastien Vigneau; Marisa S Bartolomei
Journal:  Mutat Res       Date:  2008-08-20       Impact factor: 2.433

10.  Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes.

Authors:  V Pachnis; A Belayew; S M Tilghman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more
  2 in total

1.  Lack of global epigenetic methylation defects in CBS deficient mice.

Authors:  Hyung-Ok Lee; Liqun Wang; Yin-Ming Kuo; Sapna Gupta; Michael J Slifker; Yue-Sheng Li; Andrew J Andrews; Warren D Kruger
Journal:  J Inherit Metab Dis       Date:  2016-07-21       Impact factor: 4.982

2.  Genetically defined elevated homocysteine levels do not result in widespread changes of DNA methylation in leukocytes.

Authors:  Pooja R Mandaviya; Roby Joehanes; Dylan Aïssi; Brigitte Kühnel; Riccardo E Marioni; Vinh Truong; Lisette Stolk; Marian Beekman; Marc Jan Bonder; Lude Franke; Christian Gieger; Tianxiao Huan; M Arfan Ikram; Sonja Kunze; Liming Liang; Jan Lindemans; Chunyu Liu; Allan F McRae; Michael M Mendelson; Martina Müller-Nurasyid; Annette Peters; P Eline Slagboom; John M Starr; David-Alexandre Trégouët; André G Uitterlinden; Marleen M J van Greevenbroek; Diana van Heemst; Maarten van Iterson; Philip S Wells; Chen Yao; Ian J Deary; France Gagnon; Bastiaan T Heijmans; Daniel Levy; Pierre-Emmanuel Morange; Melanie Waldenberger; Sandra G Heil; Joyce B J van Meurs
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.